KIF18A and cancer: Gleich et al. demonstrated that cancer cell lines are uniquely sensitive to pharmacological KIF18A inhibition due to weakened spindle assembly checkpoints, are intolerant to reduction in APC/C activity, and exhibit co-dependency on certain APC/C subunits (APC1, APC4, and APC8).